Astellas gets expanded approval for Symbicort asthma drug in Japan – Reuters

Astellas gets expanded approval for Symbicort asthma drug in Japan
Reuters
TOKYO, June 22 (Reuters) – Astellas Pharma Inc saidon Friday it has received approval for additional use of itsSymbicort Turbuhaler drug treatment for adult

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.